According to Lannett Company's latest financial reports the company's total liabilities are NZ$1.23 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-06-30 | NZ$1.17 B | 15.95% |
2021-06-30 | NZ$1.01 B | -21.34% |
2020-06-30 | NZ$1.29 B | 1.81% |
2019-06-30 | NZ$1.26 B | -11.96% |
2018-06-30 | NZ$1.44 B | 1.28% |
2017-06-30 | NZ$1.42 B | -16.01% |
2016-06-30 | NZ$1.69 B | 2456.38% |
2015-06-30 | NZ$66.3 M | 21.02% |
2014-06-30 | NZ$54.78 M | 8.86% |
2013-06-30 | NZ$50.32 M | -13.89% |
2012-06-30 | NZ$58.44 M | 15.13% |
2011-06-30 | NZ$50.76 M | -31.15% |
2010-06-30 | NZ$73.73 M | 0.74% |
2009-06-30 | NZ$73.2 M | 17.15% |
2008-06-30 | NZ$62.48 M | 39.34% |
2007-06-30 | NZ$44.84 M | -10.18% |
2006-06-30 | NZ$49.92 M | 33.04% |
2005-06-30 | NZ$37.52 M | 15.55% |
2004-06-30 | NZ$32.47 M | 153.3% |
2003-06-30 | NZ$12.82 M | -10.24% |
2002-06-30 | NZ$14.28 M | -55.84% |
2001-06-30 | NZ$32.34 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | NZ$193.54 B | 15,617.46% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | NZ$190.52 B | 15,372.57% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | NZ$53.39 B | 4,235.89% | ๐บ๐ธ USA |
![]() Novartis NVS | NZ$101.37 B | 8,132.75% | ๐จ๐ญ Switzerland |
![]() GlaxoSmithKline GSK | NZ$100.23 B | 8,039.71% | ๐ฌ๐ง UK |